Laws, Alison
Lagendijk, Mirelle
Grossmith, Samantha
Hughes, Melissa
Lin, Nancy U.
Mittendorf, Elizabeth A.
Eliassen, A. Heather
King, Tari A.
Dominici, Laura S.
Article History
Received: 27 July 2023
Accepted: 19 November 2023
First Online: 10 December 2023
Disclosure
: Elizabeth A. Mittendorf reports compensated service on scientific advisory boards for Astra Zeneca, BioNTech and Merck; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; speakers honoraria and travel support from Merck Sharp & Dohme; and institutional research support from Roche/Genentech (via an SU2C grant) and Gilead. She also reports research funding from Susan Komen for the Cure for which she serves as a Scientific Advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. Tari A. King reports speakers honoraria and compensated service on the scientific advisory board of Exact Sciences (formerly Genomic Health); compensated service as faculty, PrecisCa cancer information service; and compensated service for a Global Advisory Board of Berins Healthcare. Alison Laws, Mirelle Lagendijk, Samantha Grossmith, Melissa Hughes, Nancy U. Lin, A. Heather Eliassen, and Laura S. Dominici report no conflicts of interest.